A synergistic interaction between the effects of the IDH1 mutation and ketogenic metabolic therapy (KMT) could simultaneously downregulate both the Warburg effect and the Q-effect [32] in GBM neoplastic cell populations, thus providing a novel mechanism contributing to the long-term survival of the patients [33]. This evidence concerns the gene IDH1 and glioblastoma.